Tops & Flops Stocks
Security ▼ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cytocom Inc. | 13.970% | - | - | - | - | - | - |
Cymabay Therapeutics Inc | - | - | - | - | - | - | - |
Curis Inc. | -8.090% | - | - | - | - | - | - |
Cumberland Pharmaceuticals | -4.690% | - | - | - | - | - | - |
Corvus Pharmaceuticals Inc | 13.340% | 25.103% | 33.186% | 221.631% | 198.355% | 63.129% | 40.707% |
Correvio Pharma Corp. | - | - | - | - | - | - | - |
CorMedix Inc | 1.610% | 25.000% | 46.226% | 69.399% | 81.287% | 63.158% | -15.138% |
Corcept Therapeutics Inc. | 5.480% | 8.850% | 12.135% | 10.064% | 15.200% | 97.486% | 183.232% |
Corbus Pharmaceuticals Holding Inc. | -2.620% | -11.068% | -5.761% | 35514.308% | 35514.308% | 76.412% | -69.739% |
Consun Pharmaceutical Group Ltd | -3.230% | 3.333% | 39.013% | 5.085% | 16.981% | 56.566% | 24.748% |
Concert Pharmaceuticals Inc. | - | - | - | - | - | - | - |
Compugen Ltd. | -2.150% | -4.442% | 3.580% | 68.643% | 2.945% | -70.561% | - |
Collegium Pharmaceutical Inc | 0.610% | 2.500% | 3.145% | 57.692% | 19.708% | 98.788% | 192.179% |
Coherus Bioscien. | 1.760% | -24.782% | -18.208% | -79.734% | -69.368% | -93.792% | -95.284% |
co.don AG | -3.980% | - | - | - | - | - | - |
Codexis Inc. | -1.970% | 14.746% | 7.716% | 55.331% | 0.850% | -86.936% | -78.753% |
Cocrystal Pharma Inc. | 3.360% | -1.974% | -2.614% | -20.745% | -3.871% | -86.049% | - |
Clovis Oncology Inc. | - | - | - | - | - | - | - |
Clinuvel Pharmaceuticals | 0.390% | 2.327% | 6.686% | -9.233% | -7.954% | -64.141% | -43.937% |
Clinigen Group plc | - | - | - | - | - | - | - |
Cipher Pharmaceuticals | 5.210% | -17.949% | 5.495% | 215.789% | 159.459% | 511.465% | 946.322% |
Cicassia Pharmaceuticals | -2.030% | 0.000% | 4.225% | -1.987% | 5.714% | 75.355% | 296.783% |
Chugai Pharmaceutical Co Ltd | -1.940% | 3.734% | 4.133% | 52.606% | 28.225% | 33.683% | - |
Chromadex Corp | -1.950% | 4.054% | 4.054% | 124.818% | 133.333% | -41.333% | -17.658% |
Chinook Therapeutics Inc. | -1.090% | - | - | - | - | - | - |